Engene Holdings Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$1.50

-0.22 (-12.79%)

As of May 9, 1:45 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 89%

Hold 2 11%

Sell 0 0%

Price Target

Analyst Price Target +4,255.3% upside

Low Target $48.23

Average Target $65.33

High Target $96.03

Current Price $1.50

Current
$1.50

Target
$65.33

$48.23 $65.33 avg $96.03

Scenario Analysis

Bear Case

$48.23

3,115.3%

Low target

Base Case

$65.33

+4,255.3%

Avg target

Bull Case

$96.03

+6,302.0%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$12.25

-87.8% from high

52-Week Low

$1.70

+-11.8% from low

Target vs 52W High

$65.33

+433.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%